Analyst Price Target is $21.00
▲ +369.80% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Neuphoria Therapeutics Inc. - Common Stock in the last 3 months. The average price target is $21.00, with a high forecast of $21.00 and a low forecast of $21.00. The average price target represents a 369.80% upside from the last price of $4.47.
Current Consensus is
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Neuphoria Therapeutics Inc. - Common Stock.